Cite
PCSK9 regulates myofibroblast transformation through the JAK2/STAT3 pathway to regulate fibrosis after myocardial infarction.
MLA
Bao, Hailong, et al. “PCSK9 Regulates Myofibroblast Transformation through the JAK2/STAT3 Pathway to Regulate Fibrosis after Myocardial Infarction.” Biochemical Pharmacology, vol. 220, Feb. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.bcp.2023.115996.
APA
Bao, H., Wang, X., Zhou, H., Zhou, W., Liao, F., Wei, F., Yang, S., Luo, Z., & Li, W. (2024). PCSK9 regulates myofibroblast transformation through the JAK2/STAT3 pathway to regulate fibrosis after myocardial infarction. Biochemical Pharmacology, 220, N.PAG. https://doi.org/10.1016/j.bcp.2023.115996
Chicago
Bao, Hailong, Xu Wang, Haiyan Zhou, Wei Zhou, Fujun Liao, Fang Wei, Shiyu Yang, Zhenhua Luo, and Wei Li. 2024. “PCSK9 Regulates Myofibroblast Transformation through the JAK2/STAT3 Pathway to Regulate Fibrosis after Myocardial Infarction.” Biochemical Pharmacology 220 (February): N.PAG. doi:10.1016/j.bcp.2023.115996.